- Filed
- Jun 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2025 · Mar 31, 2025 | 1.46M sh |
| Shares Diluted restated | FY 2025 · Mar 31, 2024 | 762.08K sh |
| Capex | FY 2025 · Mar 31, 2025 | $13K |
| Capex | FY 2025 · Mar 31, 2024 | $42K |
| Operating Cash Flow | FY 2025 · Mar 31, 2025 | −$9.46M |
| Operating Cash Flow | FY 2025 · Mar 31, 2024 | −$14.65M |
| Cash And Equivalents | FY 2025 · Mar 31, 2025 | $11.31M |
| Cash And Equivalents | FY 2025 · Mar 31, 2024 | $2.9M |
| Stockholders Equity | FY 2025 · Mar 31, 2025 | $10.49M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $364K |
| Stockholders Equity | FY 2025 · Mar 31, 2024 | $3.6M |
| Current Liabilities | FY 2025 · Mar 31, 2025 | $3.74M |
| Current Liabilities | FY 2025 · Mar 31, 2024 | $1.86M |
| Total Liabilities | FY 2025 · Mar 31, 2025 | $4.16M |
| Total Liabilities | FY 2025 · Mar 31, 2024 | $2.75M |
| Current Assets | FY 2025 · Mar 31, 2025 | $12.13M |
| Current Assets | FY 2025 · Mar 31, 2024 | $3.94M |
| Total Assets | FY 2025 · Mar 31, 2025 | $14.65M |
| Total Assets | FY 2025 · Mar 31, 2024 | $6.35M |
| Eps Diluted | FY 2025 · Mar 31, 2025 | −$1.70 |
| Eps Diluted restated | FY 2025 · Mar 31, 2024 | −$19.25 |
| Eps Basic | FY 2025 · Mar 31, 2025 | −$1.70 |
| Eps Basic restated | FY 2025 · Mar 31, 2024 | −$19.25 |
| Sga Expense | FY 2025 · Mar 31, 2025 | $7.73M |
| Sga Expense | FY 2025 · Mar 31, 2024 | $9.7M |
| Rd Expense | FY 2025 · Mar 31, 2025 | $5.03M |
| Rd Expense | FY 2025 · Mar 31, 2024 | $5.5M |
| Net Income | FY 2025 · Mar 31, 2025 | −$2.49M |
| Net Income | FY 2025 · Mar 31, 2024 | −$14.67M |
| Operating Income | FY 2025 · Mar 31, 2025 | −$12.62M |
| Operating Income | FY 2025 · Mar 31, 2024 | −$15.09M |
| Revenue | FY 2025 · Mar 31, 2025 | $144K |
| Revenue | FY 2025 · Mar 31, 2024 | $109K |